The Value of Excipient GMP Certification
Posted on August 19, 2013
By: Irwin Silverstein, Vice President and Chief Operating Officer
IPEA
The U.S. Food & Drug Administration (FDA) has recently begun examining pharmaceutical manufacturer’s supplier qualification programs during plant inspections. This is a direct consequence of the many recent reports of economically motivated adulterations, e.g., over sulfated chondroitin sulfat...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Related Topics and Keywords
Excipient, FDA, Good Manufacturing Practices (GMP), International Pharmaceutical Excipients Auditing Inc. (IPEA)
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy
